Sale!

MAP2K2 Gene Cardiofaciocutaneous Syndrome Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MAP2K2 gene plays a critical role in the RAS/MAPK signaling pathway, which is essential for cell division, differentiation, and apoptosis. Mutations in this gene are associated with Cardiofaciocutaneous Syndrome Type 4 (CFC4), a rare genetic condition characterized by distinctive facial features, heart defects, skin abnormalities, and developmental delays.

To diagnose this condition, a genetic test focusing on the MAP2K2 gene can be conducted. This test involves analyzing the patient’s DNA to identify mutations in the MAP2K2 gene that are indicative of CFC4. It is a crucial step for families seeking answers to developmental and health concerns related to the syndrome.

At DNA Labs UAE, the test for identifying mutations in the MAP2K2 gene associated with Cardiofaciocutaneous Syndrome Type 4 is available. The cost of the test is 4400 AED. This facility employs advanced genetic testing technologies to provide accurate and reliable results, helping in the diagnosis and management of the condition. Early diagnosis through this test can significantly aid in the implementation of appropriate care and interventions, improving the quality of life for individuals with CFC4.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test

At DNA Labs UAE, we offer the MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test for individuals who may be affected by this rare genetic disorder. This test can help in diagnosing and confirming the presence of Cardiofaciocutaneous syndrome type 4 (CFC4) by analyzing the MAP2K2 gene.

Test Components and Price

The MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card for analysis.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes.

Test Type and Doctor

The MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. This test is recommended to be conducted by a cardiologist.

Test Department and Pre Test Information

The test is performed in our Genetics department. Before undergoing the MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the gene MAP2K2.

Test Details

The MAP2K2 gene is associated with Cardiofaciocutaneous syndrome type 4 (CFC4), a rare genetic disorder characterized by heart defects, distinctive facial features, and abnormalities in the skin, hair, and nails. The NGS Genetic Test involves sequencing the MAP2K2 gene to identify any variations or mutations that may be responsible for CFC4.

This genetic test is beneficial in confirming a diagnosis of CFC4 in individuals displaying characteristic symptoms. It can also be used for carrier testing in family members of affected individuals or for prenatal testing in couples with a family history of CFC4.

It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals specializing in genetics. They can provide appropriate counseling and guidance based on the test results.

Test Name MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 NGS Genetic DNA Test gene MAP2K2
Test Details

The MAP2K2 gene is associated with a genetic condition called Cardiofaciocutaneous syndrome type 4 (CFC4). CFC4 is a rare genetic disorder characterized by heart defects, distinctive facial features, and abnormalities in the skin, hair, and nails.

NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of CFC4, an NGS Genetic Test would involve sequencing the MAP2K2 gene to identify any variations or mutations that may be responsible for the condition.

This genetic test can help confirm a diagnosis of CFC4 in individuals who display characteristic symptoms. It can also be used for carrier testing in family members of affected individuals or for prenatal testing in couples with a family history of CFC4.

It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals who specialize in genetics. They can provide appropriate counseling and guidance based on the results of the test.